Merck
CN
Advanced Search
Chemical Structure Search
Search Within
Document Type

203-151-2

Applied Filters:
Keyword:'203-151-2'
Showing 1-30 of 54 results for "203-151-2" within Technical Documents
Quality Control Range Sheet- A60MG-104 and A60MG-204
12(p40) Control 1 151 – 315 pg/mL Control 2 946 - 1964 pg/mL Control 2 716 - 1488 pg/mL GM-CSF Control 1 78 – 163 pg/mL
Product Information Sheet - G4500
Neurophysiol., 84(1), 139-151 (2000). 4. Jensen, B. L., et al., Chloride is essential for contraction of afferent arterioles after agonists and potassium. Am. J. Physiol., 272(3 Pt 2), F389-396 (1997).
Product Information Sheet - A3785
Point: 144-151 °C 1 pKa: 4.05 and 8.90 at 25 °C 1 Method of preparation: A 3785 is prepared synthetically by a proprietary method. Other methods of preparation are given in references 2-5. 5-
Quality Control Range Sheet- A6602-106 and A6602-206
Control 2 506 – 1052 pg/mL Control 2 6538 – 13580 pg/mL IL-13 Control 1 186 – 386 pg/mL MDC Control 1 19 – 40 pg/mL
XP725 Antibody Number-Lot Number 071M4826
244 265 266 267 268 3.2 197 198 199 200 221 222 223 224 245 246 247 248 269 270 271 272 3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276 3.4 205 206 207
Product Information Sheet - PR0100
name Amplicon Length (bp) C9 At1g03220 245 C10 At1g21250 179 C11 At5g26920 203 C12 At4g17500 156 D1
Primary neuron culture and analysis facilitated by the CellASIC®ONIX Microfluidic Platform
Neurosci. 4(1):151-60 (1984). 20. Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 8(4-6):203-14 (1985).
Product Information Sheet - 193372
acids time (h) solvent (%) (°C) -Gly-OH 2 EtOAc 86.9 86-88 -Leu-OH•FH2O 3 EtOAc 72.0 78-84 -Met-OH•DCHA* 3 EtOAc 82.1 137-139 -Thr-OH•DCHA 3 EtOAc 99.7 151-153 -Phe-OH•DCHA 5 Ether 98.2 221-223
Calbiochem Biologics 32.2
catalytically active human PDE 11A1 expressed in Spodoptera frugiperda. Activity: ≥0.5 units/ml. 10 U € 203 Phosphodiesterase 3B, Active, Human, Recombinant, S. frugiperda 524734 A full-length, partially
141464 Parteck MXP
°C DMSO 189 °C 17.1 mg/mL 20.2 mg/mL at 50 °C DCM 40 °C 0.06 mg/mL No data available NMF 203 °C 0.06 mg/mL 19.2 mg/mL at 90 °C THF 66 °C 0.09 mg/mL 0.98 mg/mL
141464 Parteck®MXP. Technical Information.
°C DMSO 189 °C 17.1 mg/mL 20.2 mg/mL at 50 °C DCM 40 °C 0.06 mg/mL No data available NMF 203 °C 0.06 mg/mL 19.2 mg/mL at 90 °C THF 66 °C 0.09 mg/mL 0.98 mg/mL
Product Information - CSAA1
Signal Transduction M y y y 202 Phosphotyrosine Clone:PT-154 P1869 Signal Transduction M y y y 203 Phosphothreonine Clone:PTR-8 P3555 Signal Transduction M y y y 204 PKB /AKT Clone:PKB-175 P2482
App. Note Detection of pyrogens in hormone-based drugs
Luteinizing hormone and human chorionic gonadotropin: Origins of difference. Mol. Cell. Endocrinol. 383, 203–213 (2014). 16. Huhtaniemi, I. A short evolutionary history of FSH-stimulated spermatogenesis. Hormones
Appl. Note - Quantif pyrogens in Hormone
Luteinizing hormone and human chorionic gonadotropin: Origins of difference. Mol. Cell. Endocrinol. 383, 203–213 (2014). 16. Huhtaniemi, I. A short evolutionary history of FSH-stimulated spermatogenesis. Hormones
Research Focus: Volume 1, 2013
2012. Genes Dev. 26, 203. Ben-Neriah, Y., and Karin, M. 2011. Nat. Immunol. 12, 715. Oeckinghaus. A., et al. 2011. Nat. Immunol. 8, 695 Nogueira, L., et al. 2011. Oncotarget 2, 646. Naugler, W.E., and
Protocol- EZHPYTT66K
500 513 89% 562 98% Q 0 (Basal) 151 - 159 - 40 189 95% 202 108% 100 227 76% 252 93% 500 599 90% 656 99% T 0 (Basal) 136 -
Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate
Q 0 (Basal) 151 -- 159 -- 40 189 95% 202 108% 100 227 76% 252 93% 500 599 90% 656 99% T 0
Inhibitor Sourcebook 3rd Edition
Inhibits the LPA-stimulated MAP kinase kinase 1/2 (MKK1/2) activation and EGFR tyrosine phosphorylation in HeLa and NIH 3T3 cells. A 10 mM (500 µg/151 µl) solution of PD 158780 (Cat. No.513036) in DMSO
PKH Dye Reference Guide
Fluorescent Labeled Cells. Cytometry Supp 1988; 2: 4-4. (Abstract) 203. Horan P, Breslin E, Slezak S: In-Vivo Red Cell and Platelet Tracking. Cytometry Supp 1988; 2: 12-12. (Abstract) 204. Horan P, Slezak
Perfection in every dimension - Inorganic Reagents catalog
mg/l: F¯, PO4 3¯, Br¯ in H2O Certipur® 111437 203 Anion multi-element standard II 1000 mg/l: Cl¯, NO3¯, SO4 2¯ in H2O Certipur® 111448 203 Antimony ICP standard traceable to SRM from NIST
Disks and Strips for Microbiology
Interstate outbreak of Salmonella newbrunswick infection traced to powdered milk., JAMA, 203, 838 (1968) 2. J.B. Weissman, R.M.A.D. Deen, M. Williams, N. Swanston, S. Ali, An island-wide epidemic
User Guide Equinox SOP Software 2.1 for Windows XP
................. Contenido — i 193 193 193 194 194 195 198 199 199 199 200 202 202 202 203 203 203 204 204 205 205 206 206 207 207 208 208 209 209 210 210 210 211 211 213 213 213 214 214 215
CoPrime®Biochromatography System
ConfirmLevel Set confirmation level 202 NO NO NO NO NO YES SYS DBCapacity 203-SYS DBCapacity Set database capacity limit 203 NO NO NO NO NO YES SYS Explorer 204-SYS Explorer Open an explorer windows
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
Anti-phospho-MAPKAP Kinase 2 (Thr222) H Ht M Rb KA WB Rb IgG 200 µg 07-155 Anti-MAPKAP Kinase 2, long form H M WB Rb IgG 100 µg 07-241 Anti-MAPKAP Kinase 2, agarose conj. ELISA WB Rb IgG 200
XP725 Antibody List Lot 129K4831
Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855
XP725 Antibody List Lot 129K4830
Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855
XP725 Antibody List Lot 089K4791
Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855
Cytoskeletal Signaling Antibodies, Reagents and Kits
recombinant KA 10 µg 14-440 PKA Substrate Peptide KA 2 mg 12-152 PKA Substrate Peptide, biotin conj. KA 500 µg 12-394 PKA Inhibitor peptide KA 2 mg 12-151 PKC PKCα Monoclonal Antibody Anti-PKCα
Building blocks for peptide synthesis
European Peptide Symposium”, J. Martinez & J.-A. Fehrentz (Eds), Éditions EDK, Paris, 2001, pp. 203. 56. M. Cudic, et al. (2000) Tetrahedron Lett., 41, 4527. 57. J. P. Malkinson, et al. (2003) Org
Safety Connects - Solvents Withdrawal System Brochure
L 216.5 L 203 L Filling quantity 10 L 25 L 25 L 180 L 180 L Weight (empty) 1.8 kg 3.6 kg 3.4 kg 21.3 kg 21.5 kg Number per pallet 13 11 11 2 2
Page 1 of 2